293:HKEXCathay Pacific Airways Limited Analysis
Data as of 2026-03-16 - not real-time
¥1,241.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
STI Foods is trading at ¥1,241, which sits below its 20‑day (¥1,268), 50‑day (¥1,280) and 200‑day (¥1,299) moving averages, signaling a clear bearish technical backdrop. The RSI of 38 hints at oversold conditions, while the MACD histogram remains negative and the overall trend is marked as bearish, placing the next support around ¥1,235 and resistance near ¥1,295.
On the fundamentals side, the company delivers a respectable PE of 10.4 and an eye‑catching forward PE of 3.7, coupled with a low price‑to‑sales ratio of 0.57 and a dividend yield of 3.2% supported by a payout ratio under 40%, indicating sustainable income. Revenue is growing at roughly 10% annually, ROE stands at 27%, and the balance sheet shows manageable net debt after accounting for ¥3.5B in cash versus ¥4.2B of debt.
Risk metrics show low market sensitivity (beta ~0.17) and moderate 30‑day volatility (~15%). The consumer defensive sector and Japan’s stable regulatory environment keep sector and regulatory risks low, while liquidity appears solid with stable volumes. Overall, the stock appears fairly valued with a blend of growth and value traits, offering a modest upside potential for patient investors.
On the fundamentals side, the company delivers a respectable PE of 10.4 and an eye‑catching forward PE of 3.7, coupled with a low price‑to‑sales ratio of 0.57 and a dividend yield of 3.2% supported by a payout ratio under 40%, indicating sustainable income. Revenue is growing at roughly 10% annually, ROE stands at 27%, and the balance sheet shows manageable net debt after accounting for ¥3.5B in cash versus ¥4.2B of debt.
Risk metrics show low market sensitivity (beta ~0.17) and moderate 30‑day volatility (~15%). The consumer defensive sector and Japan’s stable regulatory environment keep sector and regulatory risks low, while liquidity appears solid with stable volumes. Overall, the stock appears fairly valued with a blend of growth and value traits, offering a modest upside potential for patient investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below all major SMAs indicating bearish bias
- RSI near oversold territory suggesting limited downside
- Support level at ¥1,235 providing a cushion
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong ROE and 10% revenue growth
- Forward PE of 3.7 implying significant undervaluation
- Sustainable dividend yield of 3.2% enhancing total return
Long Term
> 3 yearsNeutral
Model confidence: 8/10
Key Factors
- Low beta and defensive consumer sector mitigate market swings
- Stable cash flow and manageable debt support long‑term stability
- Consistent dividend payments provide income resilience
Key Metrics & Analysis
Financial Health
Revenue Growth9.70%
Profit Margin6.44%
P/E Ratio10.4
ROE27.00%
ROA7.79%
Debt/Equity41.93
P/B Ratio2.2
Op. Cash Flow¥2.0B
Free Cash Flow¥1.0B
Technical Analysis
TrendBearish
RSI37.9
Support¥1,235.00
Resistance¥1,295.00
MA 20¥1,268.10
MA 50¥1,280.18
MA 200¥1,298.59
MACDBearish
VolumeStable
Fear & Greed Index75.77
Valuation
Fair Value¥1,127.70
GradeFair
TypeBlend
Dividend Yield3.20%
Risk Assessment
Beta0.17
Volatility14.96%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.